-
Starting Date 1 Jan 2026 Is the job funded through the EU Research Framework Programme? Horizon Europe - MSCA Marie Curie Grant Agreement Number 101227453 Is the Job related to staff position within a
-
Fixed-term: The funds for this post are available for 3 years. A doctoral studentship is available in the forthcoming Aspirational Computing Lab (February 2026) in the Department of Computer
-
application of computational tools for the early detection and deconstruction of chromosomal instability in cancer” For further information about the research group, including their most recent publications
-
Fixed-term: The funds for this post are available for 12 months A position is available for a Postdoctoral Research Associate (Postdoc) in the forthcoming Aspirational Computing Lab in
-
Two fully-funded 3-year PhD studentships are available in Neuromorphic and Bio-inspired computing at the interface between control engineering, electrical engineering, computational neuroscience
-
the field of Computational Morphodynamics in plants. The work will be within the ERC-funded project RESYDE (https://resydeproject.org ) with the aim of building a virtual flower using multi-level data and
-
stipend at the UKRI rate (£20,780 in 2025-26 for full time students), and a contribution towards research and training costs; A personalised training programme, to develop research, communication
-
to the launch of the Bloomberg Cambridge University Corporate Bond Index later in 2025 and the delivery of the ongoing research programme related to the index project. The successful candidate will undertake desk
-
technologies, bulk and single-cell RNA-sequencing, flow cytometry, multiplex immunofluorescence, and standard molecular biology and biochemistry techniques. A computational component may also be available
-
Supervisors: Professor Sir Steve Jackson and Dr Mark O'Connor (AZ Partner) Course start date: 1st October 2026 Project details Targeted Alpha Therapy (TAT) selectively delivers high Linear Energy Transfer (LET) alpha-particles to cancer cells, maximising efficacy while minimising toxicity. ...